Navigation Links
Nuvo announces proposed amendments to outstanding convertible debentures
Date:8/1/2008

ible beyond the expected response date by exploring means of raising and conserving cash. The proposed amendments to the convertible debentures, if accepted by holders of two-thirds of the outstanding principal amount, represent the removal of a potentially large cash outlay in November, 2009."

About Nuvo Research Inc.

Nuvo is focused on the research and development of drug products delivered to and through the skin using its topical and transdermal drug delivery technologies. Nuvo's lead product is Pennsaid(R), a topical non-steroidal anti-inflammatory (NSAID) used for the treatment of osteoarthritis. Nuvo intends to leverage its skin-penetrating technologies to create a portfolio of topical and transdermal products targeting a variety of indications.

Nuvo Research Inc. is a publicly traded, Canadian pharmaceutical company headquartered in Mississauga, Ontario, with manufacturing facilities in Varennes, Quebec and Wanzleben, Germany and a research and development Center in San Diego California. For more information, please visit http://www.nuvoresearch.com.

These forward-looking statements, by their nature, necessarily involve risks and uncertainties that could cause actual results to differ materially from those contemplated by the forward-looking statements. The Company considers the assumptions on which these forward-looking statements are based to be reasonable at the time they were prepared, but caution that these assumptions regarding the future events, many of which are beyond the control of the Company and its subsidiaries, may ultimately prove to be incorrect. Factors and risks, which could cause actual results to differ materially from current expectations, are discussed in the annual reports, as well as in the Company's Annual Information Form for the year ended December 31, 2007. The Company disclaims any intention or obligation to update or revise any forward-looking st
'/>"/>

SOURCE Nuvo Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Anpath Group, Inc. Announces Appointments of David V. Gilroy and Paul A. Boyer to Board of Directors
2. Weight Watchers Announces Second Quarter 2008 Results
3. Handa Pharmaceuticals Announces Submission of its First-to-File ANDA for AstraZenecas SEROQUEL(R) XR
4. Smart Balance Announces Marketing Organization Appointment
5. Stereotaxis Announces Second Quarter 2008 Earnings Release Date and Conference Call
6. Regence Foundation Announces Three Grants Totaling $195,000
7. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
8. VA Announces New Nursing Academy Sites
9. AdCare Health Systems, Inc. Announces the Refinancing of a Nursing Home in Ohio
10. Nuvo announces second quarter 2008 financial results
11. NeoGenomics Announces Results for the Second Quarter of Fiscal Year 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 2015 , ... The American Telemedicine Association (ATA) is seeking ... exclusively on telemedicine, telehealth and mHealth. The meeting, expected to attract over 6,000 ... May 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting attracts the world’s ...
(Date:7/30/2015)... ... , ... Google recently announced that it will be disclosing any incidents involving ... June 8, 2015 article published by Nasdaq , the powerful tech company maintains ... computer-driven cars, which such industry players as Tesla CEO Elon Musk believe may very ...
(Date:7/30/2015)... Diego, CA (PRWEB) , ... July 30, 2015 ... ... has been consistently growing into one of the largest, family-owned low cost service ... across residential and commercial applications, as well as growing their company to meet ...
(Date:7/30/2015)... ... July 30, 2015 , ... " DevExpress ” was ... look at small, medium, and large businesses making an impact in their industry. ... review and shared with viewers how DevExpress has provided software development tools that ...
(Date:7/30/2015)... Orange County, CA (PRWEB) , ... July 30, ... ... of home health care throughout Orange, Riverside, Los Angeles, and San Bernardino counties, ... team as the new Palliative Care Administrator. Dr. Demoratz is a strong proponent ...
Breaking Medicine News(10 mins):Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 2Health News:24/7 Care At Home Welcomes Michael Demoratz, PhD, LCSW, CCM as New Palliative Care Administrator 3
... from Wake Forest University School of Medicine and colleagues, today's ... body fat. // ,Up until age 80, older adults ... of the obesity epidemic - they actually begin their older ... of diabetes, heart disease, high blood pressure, arthritis and disability, ...
... Fighting genes may be passed from parents to their offspring ... disharmony. //This was disclosed by a research conducted by University ... ,This study had observed 1045 adult identical and fraternal twins ... of arguing with one’s partner is passed on to their ...
... the state government and Delhi Public School (DPS) Society on ... claiming Rs 1.5 million for treatment of breast cancer. ... teacher Vibha Kapur's plea, Justice Hima Kohli asked Delhi's director ... by April 3. ,Kapoor pleaded to the court ...
... (FDA) today announced the approval of Antihemophilic Factor/von ... approved for patients undergoing surgery or invasive procedures ... hormone desmopressin is either ineffective or contraindicated. It ... (Type 3) who are undergoing major surgery. The ...
... a house to help people with dementia. //It uses smart ... thinks there may be a problem. ,The ... could mean elderly people with fading memory can now stay ... to go into care homes, reported the online edition of ...
... a plan to support doctors sagging under the pressure of overwork ... the booming oil sands areas is seeing an enormous rush of ... stationed in the region and many others comprise floating population. ... leading to burn out among the present medical staff. ...
Cached Medicine News:Health News:Obesity and Older Adults 2Health News:Ex-teacher Sues Delhi Public School 2Health News:FDA Approves New Product to Treat Von Willebrand Disease 2Health News:‘Smart House’ Developed to Monitor People With Dement 2
(Date:7/30/2015)... CHAGRIN FALLS, Ohio , July 30, 2015 /PRNewswire/ ... in his OMTEC® 2015 keynote address last month that ... business models in order to gain the efficiencies—and develop ... future. Dr. Barsoum,s comments were preceded by ... Tornier, avid entrepreneur and OMTEC moderator, who stressed that ...
(Date:7/30/2015)... Eisai Inc. announced today that regulatory applications ... , European Union and Japan ... eribulin, for the treatment of patients with inoperable soft ... advanced or metastatic disease. These regulatory ... Phase 3 clinical trial (Study 309), which met its ...
(Date:7/30/2015)... 2015  Growth of the U.S. nonprescription market is ... prescription users to the OTC market. Due to an ... Rx-to-OTC switch activity over the next five years with ... new brands entering the market into existing categories. ... years (even those with low to moderate likelihood), the ...
Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3
... Sept. 19 A single dose of ... resulted in favorable changes in hemodynamics associated ... patients with advanced heart,failure (ADHF) who participated ... on HemodynamIc Parameters in Subjects with HEart ...
... (http://www.fbcx.com ) today announced that, following the results ... an animal study at the,National Institutes of Health, FBCx ... center. The largest study to date on the,patented all- ... but not obese individuals. "Our earlier study with ...
Cached Medicine Technology:ECLIPSE Data on Effects of Otsuka's Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients' Hemodynamics and Urine Output Featured in Heart Failure Society of America's Late Breaking Trials 2ECLIPSE Data on Effects of Otsuka's Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients' Hemodynamics and Urine Output Featured in Heart Failure Society of America's Late Breaking Trials 3ECLIPSE Data on Effects of Otsuka's Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients' Hemodynamics and Urine Output Featured in Heart Failure Society of America's Late Breaking Trials 4ArtJen Announces Major Clinical Trial of Its Patented Weight Loss Product FBCx 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: